Results 21 to 30 of about 183,492 (354)

Diabetes Mellitus among Patients with Non-alcoholic Fatty Liver Disease Visiting the Outpatient Department of Internal Medicine in a Tertiary Care Centre

open access: yesJournal of Nepal Medical Association, 2023
Introduction: Diabetes mellitus is a chronic metabolic illness which is mainly associated with reduced physical activity and obesity. Diabetes mellitus and non-alcoholic fatty liver disease may coexist and synergistically lead to poor clinical outcomes.
Prabin Adhikari   +2 more
doaj   +1 more source

Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based study

open access: yesScientific Reports, 2022
Non-alcoholic fatty liver disease is the most common chronic liver disease and is associated with chronic kidney disease. The fibrosis-4 index and non-alcoholic fatty liver disease score are widely used as non-invasive diagnostic methods for non ...
Akira Mima
doaj   +1 more source

Treatments for NAFLD [PDF]

open access: yesFarmacja Polska, 2021
Non-alcoholic fatty liver disease (NAFLD) is categorised into simple steatosis, termed nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH).
Katarzyna Juszczyńska
doaj   +1 more source

To identify and examine the different causes of liver disease in Sri Lanka [PDF]

open access: yes, 2017
© 2017 The Authors. Published by International Journal of Science and Research. This is an open access article available under a Creative Commons licence.
Aslam, Fahim, Kulasena, Hashan
core   +1 more source

Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome [PDF]

open access: yes, 2016
There is evidence from animal and in-vitro studies that activation of the endocannabinoid system (EC) through cannabinoid receptor 1 (CB-1) is associated with liver injury, inflammation and hepatocellular carcinoma.1 Data suggests endogenous cannabinoids
Ahmed, Lina   +6 more
core   +1 more source

Non‐alcoholic fatty liver disease

open access: yesJournal of Diabetes, 2012
AbstractNon‐alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world. It is closely associated with metabolic syndrome. The alarming epidemics of diabetes and obesity have fueled an increasing prevalence of NAFLD, particularly among these high‐risk groups.
Ana C, Tuyama, Charissa Y, Chang
openaire   +2 more sources

Pathophysiology of Non Alcoholic Fatty Liver Disease [PDF]

open access: yesInternational Journal of Molecular Sciences, 2016
The physiopathology of fatty liver and metabolic syndrome are influenced by diet, life style and inflammation, which have a major impact on the severity of the clinicopathologic outcome of non-alcoholic fatty liver disease. A short comprehensive review is provided on current knowledge of the pathophysiological interplay among major circulating ...
Salvatore Petta   +8 more
openaire   +3 more sources

Oxidative stress: new insights on the association of nonalcoholic fatty liver disease and atherosclerosis [PDF]

open access: yes, 2015
Non-alcoholic fatty liver disease (NAFLD) represents the most common and emerging chronic liver disease worldwide. It includes a wide spectrum of liver diseases ranging from simple fatty liver to non-alcoholic steatohepatitis (NASH), which may progress ...
Albanese, Fabiana   +7 more
core   +1 more source

Immunoglobulin A and liver diseases. [PDF]

open access: yes, 2017
Immunoglobulin A (IgA) is a major immunoglobulin isotype in the gut and plays a role in maintenance of gut homeostasis. Secretory IgA (SIgA) has multiple functions in the gut, such as to regulate microbiota composition, to protect intestinal epithelium ...
Inamine, Tatsuo, Schnabl, Bernd
core   +2 more sources

The diagnosis of non‐alcoholic fatty liver disease [PDF]

open access: yesAlimentary Pharmacology & Therapeutics, 2011
no ...
Wlazlo, Nick   +4 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy